NOVEN PHARMACEUTICALS INC 4
4 · NOVEN PHARMACEUTICALS INC · Filed Jun 19, 2006
Insider Transaction Report
Form 4
STRAUSS ROBERT C
DirectorPresident, CEO & Chairman
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2006-06-16−4,588→ 57,912 totalExercise: $12.94Exp: 2006-11-30→ Common Stock ($ .0001 par value) (4,588 underlying) - Exercise/Conversion
Common Stock ($ .0001 par value)
2006-06-16$12.94/sh+4,588$59,357→ 175,937 total
Footnotes (1)
- [F1]10% exercisable after 11/30/2000; 20% exercisable after 11/30/2001; 20% exercisable after 11/30/2002; 25% exercisable after 11/30/2003; 25% exercisable after 11/30/2004.